HR Execs on the Move

Research Diets

www.researchdiets.com

 
Research Diets is a New Brunswick, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

United Methodist Communities

You will find comfort, security, and gracious services that exceed your expectations in our communities. A caring staff will provide thoughtful attention to your needs. Old friends will want to visit. New neighbors will welcome you. The amenities of shops, restaurants, entertainment, events and churches are readily accessible in town. Year after year, residents and staff award our communities the highest satisfaction ratings in an independent survey.

Memorial Healthcare System

Since its inception more than 55 years ago, Memorial Healthcare System has been a leader in providing high-quality healthcare services to South Florida residents. Today, it is the fifth-largest public healthcare system in the nation and highly regarded for its exceptional patient- and family-centered care. Memorial`s patient, physician and employee satisfaction rates are some of the most admired in the country, and the system is recognized as a national leader in quality care. To be a premier clinically integrated delivery system providing access to exceptional patient-and family-centered care, medical education, research and innovation for the benefit of the community we serve.

ProTrials Research

ProTrials Research is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AxSys Health Corp

AxSys Health Corp is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cleveland Biolabs

Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications. We have additional pipeline product candidates in various stages of development.